PLUS THERAPEUTICS, INC. — Director's Dealing 2016

May 16, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2016-05-13

Reporting Person: HARRIS JOHN DAVID (VP and GM Cell Therapy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-13	Common Stock	P	2000	$2.71	Acquired	2000	Direct